[Experience of using of octreotide-depot in prevention of the development and treatment of external pancreatic fistulas of different genesis].

In the period from 2011 till 2012 the Otcreotide-depot was used by the authors in treatment of 34 patients. The patients were divided into two groups: the first group--the prevention of development and the second group--the treatment of external pancreatic fistulas. Ocreotide-depot was applied in 17 patient of the first group: as part of the complex therapy of severe pancreatitis in 4 patients and after pacreaticoduodenectomy in 13 patients.

[Leukofibrinolysis enhanced by leukocyte adhesion to a clot with antifibrin antibodies].

The possibility of intensifying the thrombolytic action of circulating leukocytes was studied in experiments in vitro. Sixty-five cells per unit of gel surface adhered to an intact fibrin clot. Treatment of the fibrin clot with fibrinogen antiserum increased the number of adhering cells to 863.

[Development of a high fibrinolytic potential around a thrombus using leukocyte Fc receptors loaded with streptase].

An effective way of inducing high fibrinolytic potential in the thrombus area by streptase-containing leucocytes has been suggested. Leucocytes were incubated with streptase and then placed in the solution containing a fibrin clot, the latter pre-treated with anti-fibrin serum. In these conditions the rate of fibrinolysis increased drastically.